
Take one when you want it
PT-141 Troches
You want the cheapest way in and two strengths to choose from.
PT-141 online carePrivate visit, licensed provider, pharmacy delivery
PT-141 · online care
A private written visit for PT-141, reviewed by a U.S.-licensed provider. From $54.50 your first month.
Nobody wants to open this conversation in a waiting room. You write it down instead, a licensed clinician reads it properly, and a pharmacy ships in plain packaging.
Prefer to read first? See the prices.

What happens after you click
Nothing here needs you to take a morning off or repeat yourself to a receptionist.
A private set of questions about desire, your medicines, your blood pressure, your heart history, and what you have already tried. No phone call and no waiting room.
A U.S.-licensed clinician reviews your answers and decides whether PT-141 fits, which route suits you, and which strength to start at.
Your directions are written for you: placement or timing, how often, and what to watch for. That label, not a web page, is your instruction sheet.
A licensed U.S. compounding pharmacy prepares your PT-141 to order and ships it cold in plain packaging with free delivery. Move it to the fridge when it lands.
Message your care team about timing, a strength change, a route change, side effects, or refills. Pause or cancel before the next shipment.
Where it is made
Kaduceus is a licensed 503A compounding pharmacy in the United States. A 503A pharmacy compounds against a prescription written for one patient, which is why the label on your bottle carries your name, your active, and your strength. Nothing about it came off a shelf, and nothing about it was ordered by someone else.
A licensed U.S. provider signs every prescription. Compounded medications are prepared for one patient against that prescription.

What the provider needs
PT-141 is not a lifestyle supplement and the review is not a formality. These are the parts of your visit that actually change what a provider prescribes.
Bremelanotide's approved label is contraindicated in uncontrolled high blood pressure and known cardiovascular disease. This is the first thing a provider needs from you.
Prescriptions, over-the-counter medicines, and supplements. Naltrexone is called out on the approved label, and any PDE5 medicine you already use matters here.
How long it has been going on, whether it is new, and what changed around the time it started. That shapes the route and the strength.
Both change the decision. Say so in the visit rather than waiting to be asked.

Verified Rebody customers
Rebody customers on what the visit and the care team were actually like.
I almost canceled the appointment because this was not an easy subject for me to talk about. My Rebody doctor was kind, professional and made me comfortable from the first conversation. The PT-141 troches have made a real difference in my desire and in my relationship with my husband. Everything arrived discreetly, and customer service has been wonderful.
I was uncomfortable bringing this up, but my Rebody doctor made the conversation feel normal. The PT-141 troches have helped with desire, and things feel more spontaneous with my husband again. The package was discreet and arrived when expected.
I almost did not write a review because this is such a private topic, but maybe it will help someone else. My desire had been gone for a long time and it was creating distance between my husband and me. My Rebody doctor treated me with kindness and zero judgment, and the PT-141 spray has made intimacy feel natural and spontaneous again. The change in our relationship has been incredible. I am deeply grateful for the care I received.
Begin here
Your choice carries into the visit. A provider can move you to the other route later if it suits you better.

Take one when you want it
You want the cheapest way in and two strengths to choose from.

Use it 30 to 60 minutes ahead
You want the route with early human intranasal research behind it.
Care questions
Providers, pharmacy, packaging, states, refills, and how to change your plan.
The visit is written. You answer the questions in your own time. If a provider needs something more, they message you in the portal rather than calling you at work.
A U.S.-licensed clinician reviews your visit and makes the prescribing decision. Rebody does not sell prescription treatment without that review.
A licensed U.S. compounding pharmacy prepares your PT-141 to order and ships it directly to you.
Plain. There is no branding on the outside that names the medication or what it treats.
Prescription treatment is not available in every state. The visit checks your location before a provider reviews it.
Refills arrive on your monthly plan at the same price. To change strength or route, message your care team and a provider reviews it before the next shipment.
Important safety information
Bremelanotide's approved label is contraindicated in uncontrolled high blood pressure and in known cardiovascular disease. Tell your provider your blood pressure, your heart history, every medicine and supplement you take, whether you take naltrexone, and whether you are pregnant or breastfeeding.
Nausea, flushing, and headache were the reactions most often reported in bremelanotide trials. The approved label also covers a temporary rise in blood pressure, a fall in heart rate, and darkening of skin in patches. Get urgent care for hives, swelling, trouble breathing, chest tightness, or fainting.
The FDA-approved bremelanotide product is Vyleesi, a 1.75 mg subcutaneous autoinjector for acquired, generalized hypoactive sexual desire disorder in premenopausal women. Rebody's troche and nasal spray are compounded prescription medications. They are a different product and they do not carry that approval or that indication.
Compounded medications are not FDA-approved or evaluated by the FDA for safety, efficacy, or quality. Prescription treatment requires a provider decision and is not available in every state.
PT-141 online care
From $54.50 for your first month, with the licensed provider review, the pharmacy, and delivery included.